Data & AI
Diversity in Clinical Trials: How Pharmaceutical Companies Can Achieve Success Amidst Regulatory Focus
Reading Time: 3 minutesDiversity in clinical trials has been a long-standing issue across clinical research. Studies… Read More
Medidata AI: New Research on Concurrence of CRS and ICANS in CAR T-cell Treatments
Reading Time: < 1 minutesChimeric antigen receptor (CAR) T-cell treatment is a promising immunotherapy… Read More
4 Ways Linking CAR-T Therapy Patients to Real-world Data Is Future-proofing Clinical Development
Reading Time: 4 minutesChimeric antigen receptor T-cell (CAR-T) therapies have demonstrated significant… Read More
Accelerating Generalizability of Cancer Clinical Trial Results
Reading Time: 4 minutesSubstantial research suggests that patients participating in cancer clinical trials of new therapies… Read More
2022: A Remarkable Year for External Control Arms in Clinical Trials
Reading Time: 5 minutes2022 was a remarkable year for external control arms (ECAs) in… Read More
Case Study: A Clinical-Stage Biopharmaceutical Company Saves $800K in Data Costs and Doubles Patient-Level Data Coverage with Medidata AI
Reading Time: 3 minutesSummary After investing years and significant resources in clinical… Read More
Medidata AI & Imunon Publish Findings in ASCO Journal of Clinical Oncology that Show a Historic Clinical Trial External Control Arm Provides an Actionable Efficacy Estimate Prior to a Randomized Trial
Reading Time: 2 minutesMedidata and Imunon Corporation—a… Read More
How Data Linkage Improves Long-term Safety and Effectiveness Tracking for Biopharma Sponsors
Reading Time: 2 minutesData linkage—the process of connecting clinical trial… Read More
How Data Linkage Helps Biopharma Sponsors Quantify Healthcare Resource Utilization (HCRU)
Reading Time: 3 minutesData linkage—the process of connecting clinical trial… Read More
How to Use Data Linkage to Track Clinical Trial Patients Lost to Follow-Up
Reading Time: 2 minutesData linkage—the process of connecting clinical trial… Read More
